| 1 |
31479512 | Relationship between protein biomarkers of chemotherapy response and microsatellite status, tumor mutational burden and PD-L1 expression in cancer patients. | 2020 Jun 1 |
1 |
| 2 |
32118594 | Prognostic and Predictive Role of Excision Repair Cross-complementation Group 1 and Thymidylate Synthase in Colorectal Carcinoma Patients Received FOLFOX Chemotherapy: An Immunohistochemical Study. | 2020 Nov/Dec |
1 |
| 3 |
29330293 | Differential Regulation of LET-7 by LIN28B Isoform-Specific Functions. | 2018 Mar |
1 |
| 4 |
29399358 | Predictive biomarkers for combined chemotherapy with 5-fluorouracil and cisplatin in oro- and hypopharyngeal cancers. | 2018 Feb |
1 |
| 5 |
30011079 | Effect of 5-fluorouracil on excision repair cross-complementing 1 expression and consequent cytotoxicity regulation in human gastric cancer cells. | 2018 Nov |
6 |
| 6 |
24318989 | Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy. | 2014 Apr |
2 |
| 7 |
24403450 | ERCC1 expression and chemosensitivity in uterine cervical adenocarcinoma cells. | 2014 Jan |
7 |
| 8 |
24520224 | Combination of TRAP1 and ERCC1 Expression Predicts Clinical Outcomes in Metastatic Colorectal Cancer Treated with Oxaliplatin/5-Fluorouracil. | 2014 Jan |
4 |
| 9 |
25083297 | Breast cancer resistance protein (BCRP) and excision repair cross complement-1 (ERCC1) expression in esophageal cancers and response to cisplatin and irinotecan based chemotherapy. | 2014 Aug |
1 |
| 10 |
25175730 | Association between ERCC1 and TS mRNA levels and disease free survival in colorectal cancer patients receiving oxaliplatin and fluorouracil (5-FU) adjuvant chemotherapy. | 2014 Aug 29 |
3 |
| 11 |
25366763 | Study on the ERCC1 gene polymorphism response to chemotherapy and prognosis of gastric cancer. | 2014 Oct 27 |
1 |
| 12 |
23332421 | Role of conventional chemosensitivity test and tissue biomarker expression in predicting response to treatment of peritoneal carcinomatosis from colon cancer. | 2013 Jun |
1 |
| 13 |
23481186 | ERCC1, defective mismatch repair status as predictive biomarkers of survival for stage III colon cancer patients receiving oxaliplatin-based adjuvant chemotherapy. | 2013 Apr 2 |
1 |
| 14 |
23762305 | Synergistic anticancer effects of polyphyllin I and evodiamine on freshly-removed human gastric tumors. | 2013 |
1 |
| 15 |
23962907 | ERCC1 C8092A (rs3212986) polymorphism as a predictive marker in esophageal cancer patients treated with cisplatin/5-FU-based neoadjuvant therapy. | 2013 Nov |
3 |
| 16 |
21940361 | Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer. | 2012 Jan-Feb |
2 |
| 17 |
22567180 | ERCC1 C118T associates with response to FOLFOX4 chemotherapy in colorectal cancer patients in Han Chinese. | 2012 |
1 |
| 18 |
23020798 | Polymorphisms in ERCC1, GSTs, TS and MTHFR predict clinical outcomes of gastric cancer patients treated with platinum/5-Fu-based chemotherapy: a systematic review. | 2012 Sep 29 |
1 |
| 19 |
23169295 | Upregulation of ERCC1 and DPD expressions after oxaliplatin-based first-line chemotherapy for metastatic colorectal cancer. | 2012 Dec 4 |
1 |
| 20 |
21868518 | Prognostic significance of thymidylate synthase expression in the adjuvant chemotherapy after resection for pulmonary metastases from colorectal cancer. | 2011 Sep |
1 |
| 21 |
22110208 | Relationship between TYMS and ERCC1 mRNA expression and in vitro chemosensitivity in colorectal cancer. | 2011 Nov |
6 |
| 22 |
22202337 | [The Relationship between the efficacy of mFOLFOX6 treatment and the expression of TS, DPD, TP, and ERCC-1 in unresectable colorectal cancer]. | 2011 Nov |
2 |
| 23 |
21029695 | [Association between genetic polymorphisms of ERCC1, XRCC1, GSTP1 and survival of advanced gastric cancer patients treated with oxaliplatin/5-Fu-based chemotherapy]. | 2010 Jul |
2 |
| 24 |
21224584 | [ERCC1 and TS expression in chemoradiotherapy treated esophageal squamous cell carcinoma]. | 2010 Nov |
2 |
| 25 |
21224630 | [The expression of thymidylate synthase (TS) and excision repair complementing-1 (ERCC-1) protein in patients with unresectable colorectal cancer treated with mFOLFOX6 therapy]. | 2010 Nov |
2 |
| 26 |
19194123 | Prognostic value of ERCC1, thymidylate synthase, and glutathione S-transferase pi for 5-FU/oxaliplatin chemotherapy in advanced colorectal cancer. | 2009 Feb |
6 |
| 27 |
18497992 | Mechanism of resistance to chemoradiation in p53 mutant human colon cancer. | 2008 Jun |
3 |
| 28 |
19020759 | Messenger RNA expression of TS and ERCC1 in colorectal cancer and matched liver metastasis. | 2008 Dec |
2 |
| 29 |
21885003 | Can we customize chemotherapy? Individualizing cytotoxic regimens in advanced non-small-cell lung cancer. | 2008 Mar |
1 |
| 30 |
17322540 | Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer. | 2007 Mar |
2 |
| 31 |
17607914 | Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. | 2007 |
1 |
| 32 |
17016597 | The optimal schedule for 5-fluorouracil radiosensitization in colon cancer cell lines. | 2006 Nov |
1 |
| 33 |
16144923 | ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer. | 2005 Sep 1 |
1 |
| 34 |
16243820 | Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. | 2005 Oct 15 |
1 |
| 35 |
11731512 | ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy. | 2001 Dec 1 |
3 |
| 36 |
9440758 | ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. | 1998 Jan |
1 |
| 37 |
9268987 | Inhibition by 5-fluorouracil of ERCC1 and gamma-glutamylcysteine synthetase messenger RNA expression in a cisplatin-resistant HST-1 human squamous carcinoma cell line. | 1997 |
5 |